Susquehanna International Group, LLP Reviva Pharmaceuticals Holdings, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.64 - $1.48 $10,048 - $23,236	-15,700 Reduced 44.1%	19,900 $28,000
Q2 2024 Aug 15, 2024	SELL	$1.25 - $3.79 $23,375 - $70,873	-18,700 Reduced 34.44%	35,600 $45,000
Q1 2024 May 07, 2024	SELL	$2.76 - $5.52 $810,611 - $1.62 Million	-293,700 Reduced 84.4%	54,300 $205,000
Q4 2023 Feb 14, 2024	SELL	$3.56 - $6.04 $388,396 - $658,964	-109,100 Reduced 23.87%	348,000 $1.79 Million
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.9 $1.19 Million - $1.8 Million	304,500 Added 199.54%	457,100 $2.23 Million
Q2 2023 Aug 11, 2023	BUY	$4.42 - $8.55 $141,882 - $274,455	32,100 Added 26.64%	152,600 $894,000
Q1 2023 May 16, 2023	BUY	$3.79 - $4.87 $110,289 - $141,717	29,100 Added 31.84%	120,500 $504,000
Q4 2022 Feb 14, 2023	SELL	$1.68 - $5.99 $28,224 - $100,632	-16,800 Reduced 15.53%	91,400 $388,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $2.66 $15,148 - $287,812	108,200 New	108,200 $172,000

9.96M

133K

43.9K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $23.1M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.